227 related articles for article (PubMed ID: 33106495)
1. T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis.
Napier RJ; Lee EJ; Davey MP; Vance EE; Furtado JM; Snow PE; Samson KA; Lashley SJ; Brown BR; Horai R; Mattapallil MJ; Xu B; Callegan MC; Uebelhoer LS; Lancioni CL; Vehe RK; Binstadt BA; Smith JR; Caspi RR; Rosenzweig HL
Nat Commun; 2020 Oct; 11(1):5406. PubMed ID: 33106495
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation.
Zurek B; Proell M; Wagner RN; Schwarzenbacher R; Kufer TA
Innate Immun; 2012 Feb; 18(1):100-11. PubMed ID: 21310790
[TBL] [Abstract][Full Text] [Related]
3. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing in three children with sporadic Blau syndrome, one of them co-presenting with recurrent polyserositis.
Córdova-Fletes C; Rangel-Sosa MM; Martínez-Jacobo LA; Becerra-Solano LE; Arellano-Valdés CA; Tlacuilo-Parra JA; Galán-Huerta KA; Rivas-Estilla AM; Hernandez-Orozco AA; García-Ortiz JE
Autoimmunity; 2020 Sep; 53(6):344-352. PubMed ID: 32597225
[TBL] [Abstract][Full Text] [Related]
5. A Novel Pathogenic
Rodrigues FG; Petrushkin H; Webster AR; Bickerstaff M; Moraitis E; Rowczenio D; Aróstegui JI; Westcott M
Ophthalmic Genet; 2021 Dec; 42(6):753-764. PubMed ID: 34251956
[TBL] [Abstract][Full Text] [Related]
6. Blau Syndrome: NOD2-related systemic autoinflammatory granulomatosis.
Takada S; Saito MK; Kambe N
G Ital Dermatol Venereol; 2020 Oct; 155(5):537-541. PubMed ID: 32618442
[TBL] [Abstract][Full Text] [Related]
7. Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis.
Napier RJ; Lee EJ; Vance EE; Snow PE; Samson KA; Dawson CE; Moran AE; Stenzel P; Davey MP; Sakaguchi S; Rosenzweig HL
J Immunol; 2018 Oct; 201(7):1889-1898. PubMed ID: 30150283
[TBL] [Abstract][Full Text] [Related]
8. Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis.
Zhong Z; Ding J; Su G; Liao W; Gao Y; Zhu Y; Deng Y; Li F; Du L; Gao Y; Yang P
Ophthalmology; 2022 Jul; 129(7):821-828. PubMed ID: 35314268
[TBL] [Abstract][Full Text] [Related]
9. Blau syndrome revisited.
Rose CD; Martin TM; Wouters CH
Curr Opin Rheumatol; 2011 Sep; 23(5):411-8. PubMed ID: 21788900
[TBL] [Abstract][Full Text] [Related]
10. A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.
Ong LT; Nachbur U; Rowczenio D; Ziegler JB; Fischer E; Lin MW
Innate Immun; 2017 Oct; 23(7):578-583. PubMed ID: 28836875
[TBL] [Abstract][Full Text] [Related]
11. Role of NOD2 Pathway Genes in Sarcoidosis Cases with Clinical Characteristics of Blau Syndrome.
Bello GA; Adrianto I; Dumancas GG; Levin AM; Iannuzzi MC; Rybicki BA; Montgomery C
Am J Respir Crit Care Med; 2015 Nov; 192(9):1133-5. PubMed ID: 26517420
[No Abstract] [Full Text] [Related]
12. Brief Report: First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism.
Mensa-Vilaro A; Cham WT; Tang SP; Lim SC; González-Roca E; Ruiz-Ortiz E; Ariffin R; Yagüe J; Aróstegui JI
Arthritis Rheumatol; 2016 Apr; 68(4):1039-44. PubMed ID: 26606664
[TBL] [Abstract][Full Text] [Related]
13. Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency.
Parackova Z; Bloomfield M; Vrabcova P; Zentsova I; Klocperk A; Milota T; Svaton M; Casanova JL; Bustamante J; Fronkova E; Sediva A
J Clin Immunol; 2020 Jan; 40(1):165-178. PubMed ID: 31760574
[TBL] [Abstract][Full Text] [Related]
14. A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?
Inoue Y; Kawaguchi Y; Shimojo N; Yamaguchi K; Morita Y; Nakano T; Arima T; Tomiita M; Kohno Y
Mod Rheumatol; 2013 Jul; 23(4):837-9. PubMed ID: 22821420
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation.
Jimenez-Martinez MC; Cruz F; Groman-Lupa S; Zenteno JC
Int J Immunogenet; 2011 Jun; 38(3):233-42. PubMed ID: 21320290
[TBL] [Abstract][Full Text] [Related]
17. Blau syndrome, the prototypic auto-inflammatory granulomatous disease.
Wouters CH; Maes A; Foley KP; Bertin J; Rose CD
Pediatr Rheumatol Online J; 2014; 12():33. PubMed ID: 25136265
[TBL] [Abstract][Full Text] [Related]
18. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
19. Familial Blau syndrome without uveitis caused by a novel mutation in the nucleotide-binding oligomerization domain-containing protein 2 gene with good response to infliximab.
Toral-López J; González-Huerta LM; Martín-Del Campo M; Messina-Baas O; Cuevas-Covarrubias SA
Pediatr Dermatol; 2018 May; 35(3):e180-e183. PubMed ID: 29570830
[TBL] [Abstract][Full Text] [Related]
20. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.
Okafuji I; Nishikomori R; Kanazawa N; Kambe N; Fujisawa A; Yamazaki S; Saito M; Yoshioka T; Kawai T; Sakai H; Tanizaki H; Heike T; Miyachi Y; Nakahata T
Arthritis Rheum; 2009 Jan; 60(1):242-50. PubMed ID: 19116920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
